Sebastjan Bevc

2.0k total citations
108 papers, 1.4k citations indexed

About

Sebastjan Bevc is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sebastjan Bevc has authored 108 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Nephrology, 28 papers in Surgery and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sebastjan Bevc's work include Dialysis and Renal Disease Management (42 papers), Chronic Kidney Disease and Diabetes (30 papers) and Blood Pressure and Hypertension Studies (13 papers). Sebastjan Bevc is often cited by papers focused on Dialysis and Renal Disease Management (42 papers), Chronic Kidney Disease and Diabetes (30 papers) and Blood Pressure and Hypertension Studies (13 papers). Sebastjan Bevc collaborates with scholars based in Slovenia, United States and Norway. Sebastjan Bevc's co-authors include Radovan Hojs, Robert Ekart, Nina Hojs, Maksimiljan Gorenjak, Ludvik Puklavec, Nejc Piko, Uroš Maver, Vojko Kanič, Andraž Stožer and Breda Pečovnik Balon and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Clinica Chimica Acta.

In The Last Decade

Sebastjan Bevc

97 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sebastjan Bevc Slovenia 21 665 264 185 176 160 108 1.4k
Sandrine Lemoine France 17 543 0.8× 105 0.4× 199 1.1× 190 1.1× 177 1.1× 93 1.2k
Teresa Faga Italy 21 699 1.1× 137 0.5× 214 1.2× 179 1.0× 167 1.0× 43 1.3k
Daphne H. Knicely United States 3 445 0.7× 165 0.6× 120 0.6× 122 0.7× 170 1.1× 6 1.1k
Mercedes Muros Spain 22 421 0.6× 165 0.6× 323 1.7× 166 0.9× 232 1.4× 32 1.4k
A Naso Italy 20 682 1.0× 151 0.6× 188 1.0× 385 2.2× 203 1.3× 45 1.6k
Sahir Kalim United States 23 618 0.9× 151 0.6× 223 1.2× 190 1.1× 414 2.6× 59 1.5k
Michael Hultström Sweden 24 329 0.5× 252 1.0× 224 1.2× 162 0.9× 301 1.9× 115 1.8k
Robert Ekart Slovenia 24 925 1.4× 489 1.9× 324 1.8× 470 2.7× 210 1.3× 121 2.1k
So‐Young Lee South Korea 25 559 0.8× 133 0.5× 190 1.0× 392 2.2× 477 3.0× 105 1.9k
Tsutomu Sanaka Japan 19 464 0.7× 196 0.7× 117 0.6× 345 2.0× 150 0.9× 104 1.4k

Countries citing papers authored by Sebastjan Bevc

Since Specialization
Citations

This map shows the geographic impact of Sebastjan Bevc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastjan Bevc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastjan Bevc more than expected).

Fields of papers citing papers by Sebastjan Bevc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastjan Bevc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastjan Bevc. The network helps show where Sebastjan Bevc may publish in the future.

Co-authorship network of co-authors of Sebastjan Bevc

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastjan Bevc. A scholar is included among the top collaborators of Sebastjan Bevc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastjan Bevc. Sebastjan Bevc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morales, Enrique, Trond Jenssen, Sebastjan Bevc, et al.. (2025). Obesity as a modifiable risk factor in patients with chronic kidney disease. Nephrology Dialysis Transplantation.
2.
3.
Hojs, Nina, et al.. (2024). Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID‐19. Therapeutic Apheresis and Dialysis. 28(6). 941–950. 4 indexed citations
4.
Ekart, Robert, et al.. (2024). Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. International Journal of Molecular Sciences. 25(16). 9088–9088.
5.
Piko, Nejc, Sebastjan Bevc, Radovan Hojs, & Robert Ekart. (2024). Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease. Pharmaceuticals. 17(4). 418–418. 14 indexed citations
6.
7.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2023). Chronic Kidney Disease and Obesity. ˜The œNephron journals/Nephron journals. 147(11). 660–664. 27 indexed citations
8.
Piko, Nejc, Sebastjan Bevc, Radovan Hojs, & Robert Ekart. (2023). The Role of Oxidative Stress in Kidney Injury. Antioxidants. 12(9). 1772–1772. 33 indexed citations
9.
Piko, Nejc, Sebastjan Bevc, Radovan Hojs, & Robert Ekart. (2023). Atherosclerosis and Epigenetic Modifications in Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 147(11). 655–659. 2 indexed citations
10.
Piko, Nejc, et al.. (2021). Atherosclerosis, epigenetic modifications, and arterial stiffness. 10(2). 10–17. 3 indexed citations
11.
Ekart, Robert, et al.. (2021). Early Detection of Arteriovenous Fistula Stenosis in Hemodialysis Patients through Routine Measurements of Dialysis Dose (Kt/V). Blood Purification. 51(1). 15–22. 3 indexed citations
12.
Hojs, Nina, Robert Ekart, Sebastjan Bevc, Nejc Piko, & Radovan Hojs. (2021). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients. American Journal of Nephrology. 52(5). 404–411. 9 indexed citations
13.
Šalamon, Špela, Sebastjan Bevc, Robert Ekart, Radovan Hojs, & Uroš Potočnik. (2021). Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure. Genes. 12(6). 834–834. 5 indexed citations
14.
Hojs, Nina, et al.. (2021). Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals. 14(6). 561–561. 20 indexed citations
15.
Hojs, Nina, Sebastjan Bevc, Robert Ekart, & Radovan Hojs. (2020). Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy. Antioxidants. 9(10). 925–925. 128 indexed citations
16.
Bevc, Sebastjan, et al.. (2019). The effect of high‐flux hemodialysis and post‐dilution hemodiafiltration on platelet closure time in patients with end stage renal disease. Hemodialysis International. 23(3). 319–324. 1 indexed citations
17.
Kanič, Vojko, et al.. (2018). Impact of KDIGO-Defined Acute Kidney Injury on Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction. Cardiorenal Medicine. 8(4). 332–339. 16 indexed citations
18.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2016). Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. ˜The œNephron journals/Nephron journals. 133(3). 159–162. 52 indexed citations
19.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2015). Biomarkers of Renal Disease and Progression in Patients with Diabetes. Journal of Clinical Medicine. 4(5). 1010–1024. 36 indexed citations
20.
Hojs, Radovan, et al.. (2007). the prevalence of chronic kidney disease in patients with acute coronary syndrome. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Lemoine Breakdown of academic impact, for papers by Teresa Faga Breakdown of academic impact, for papers by Daphne H. Knicely Breakdown of academic impact, for papers by Mercedes Muros Breakdown of academic impact, for papers by A Naso Breakdown of academic impact, for papers by Sahir Kalim Breakdown of academic impact, for papers by Michael Hultström Breakdown of academic impact, for papers by Robert Ekart Breakdown of academic impact, for papers by So‐Young Lee Breakdown of academic impact, for papers by Tsutomu Sanaka
Rankless by CCL
2026